| 1 |
Lee SR, Choi EK, Han KD, Cha MJ, Oh S. Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the CHA2DS2-VASc score in the entire Korean population. Int J Cardiol 2017;236:226-31.
DOI
|
| 2 |
Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016;37:2893-962.
DOI
|
| 3 |
Schotten U, Verheule S, Kirchhof P, Goette A. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev 2011;91:265-325.
DOI
|
| 4 |
Nguyen BL, Fishbein MC, Chen LS, Chen PS, Masroor S. Histopathological substrate for chronic atrial fibrillation in humans. Heart Rhythm 2009;6:454-60.
DOI
|
| 5 |
Gudbjartsson DF, Arnar DO, Helgadottir A, et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 2007;448:353-7.
DOI
|
| 6 |
Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994;271:840-4.
DOI
|
| 7 |
Aviles RJ, Martin DO, Apperson-Hansen C, et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003;108:3006-10.
DOI
|
| 8 |
Lim WH, Choi EK, Han KD, et al. Proteinuria detected by urine dipstick test as a risk factor for atrial fibrillation: a nationwide population-based study. Sci Rep 2017;7:6324.
DOI
|
| 9 |
Lee KH, Shin MH, Park HW, Cho JG, Kweon SS, Lee YH. Association between serum parathyroid hormone levels and the prevalence of atrial fibrillation: the Dong-gu study. Korean Circ J. 2018;48:159-67.
DOI
|
| 10 |
Cha MJ, Lee HS, Kim HM, Jung JH, Choi EK, Oh S. Association between red cell distribution width and thromboembolic events in patients with atrial fibrillation. Eur J Intern Med 2017;46:41-6.
DOI
|
webmaster
